Mass. Movers

Parexel moves higher on analyst upgrade

Josef H. von Rickenbach is the CEO of Parexel.

Essdras M Suarez/Globe Staff/File

Josef H. von Rickenbach is the CEO of Parexel.


Shares of Parexel International Corp. rose after the Waltham biopharmaceutical services company was upgraded by ISI Group from “neutral” to “buy” in a research note, according to The firm currently has a $57 price objective on the stock, up from $52.50. ISI Group’s target price indicates a potential upside of 14.73 percent from the stock’s previous close. In August, Parexel reported earnings per share of 50 cents for the quarter, beating estimates.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of